Denuncia a farmaceutica porque medicamento le causo adiccion

¿Adicto al sexo gay por un medicamento?

Un hombre casado ha denunciado a los fabricantes de un medicamento contra el párkinson porque asegura que como consecuencia de la medicación se ha vuelto un adicto al sexo gay.

El protagonista de la denuncia se llama Didier Jambart, tiene 51 años y está convencido de que su travestismo y su adicción a los juegos de azar en Internet son efectos secundarios del medicamento, según publica la prensa británica.

Pide una indemnización millonaria porque ha perdido entre 70.000 y 110.000 euros en los juegos internáuticos, según él por culpa del maldito medicamento. Y digo yo, que soy un tipo muy incrédulo y malicioso. ¿No será que se ha vuelto adicto al juego, se ha pulido ese dineral y ahora necesita sacarlo de donde sea? Pregunto.

Married man sues pharmaceutical giant over claims Parkinson's disease treatment tablet turned him into a psychotic gay sex addict

A MARRIED dad is suing the makers of a drug he took for Parkinson’s disease, claiming it turned him into a psychotic gay sex addict.
Didier Jambart, 51, says the drastic side-effects also saw him start cross-dressing and get hooked on internet gambling.
He is demanding £400,000 damages from pharmaceutical giant GlaxoSmithKline, the makers of Requip, and his consultant.
Revealing his torment, the ex-bank worker and town councillor blames the drug for his three suicide attempts.
Soon after being prescribed the pills in 2003 his behaviour changed. But he said: “Then my neurologist increased the dose and I completely lost the plot. I stole bank cards from friends and used them to gamble. I also sold my children’s toys and I borrowed money. In total I lost between £60,000 to £90,000 online.”

He revealed: “I started seeking out sex with men and exhibiting myself on the internet. Those around me could simply not understand what was going on.”
The dad-of-two stopped taking the pills in 2006 after reading about other cases on the internet and returned to normal, he says. His wife has stood by him throughout, although he says they are now outcasts at home in Nantes, western France.
He is suing Middlesex-based Glaxo as he says the firm only printed warnings about potential side-effects in 2006 – three years late.
Mr Jambart said: “I want to get my dignity back.”
Requip alters dopamine levels in the brain to treat Parkinson’s, which affects the nervous system.
Glaxo refused to comment on the case.